These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4760367)

  • 41. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract]   [Full Text] [Related]  

  • 42. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 43. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 44. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of the sphygmic periods and segmental pressure in the limbs of normal subjects and arteriopathic patients].
    Picchione N; Caini B
    Cardiol Prat; 1976; 27(2):83-95. PubMed ID: 1026355
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs].
    Ehringer H; Scheiber V
    Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of peripheral circulation disorders with 1-benzyl-1-(3-dimethyl-amino-propoxy)-cycloheptane].
    Denck H
    Wien Med Wochenschr; 1973 Mar; 123(11):174-8. PubMed ID: 4692075
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G; Carre A; Ginestet A; Lambert M
    Lille Med; 1976 Dec; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract]   [Full Text] [Related]  

  • 49. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hemodynamics in arterial insufficiency].
    Lambert J
    Acta Clin Belg Suppl; 1976; 9():1-245. PubMed ID: 1072336
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of peripheral arterial diseases].
    Mikita J
    Orv Hetil; 2005 May; 146(22):1209-11. PubMed ID: 15997667
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of mechanical oscillography in the study of peripheral arterial diseases].
    Romeo S; Spinella G
    Minerva Cardioangiol; 1975 Feb; 23(2):73-82. PubMed ID: 1143654
    [No Abstract]   [Full Text] [Related]  

  • 53. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
    Caspary L; Creutzig A; Alexander K
    Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
    [No Abstract]   [Full Text] [Related]  

  • 54. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 55. Strain gauge pulse recording in postoperative management of vascular reconstruction.
    Hallböök T
    Scand J Clin Lab Invest Suppl; 1973; 128():193-5. PubMed ID: 4764580
    [No Abstract]   [Full Text] [Related]  

  • 56. [Arterial insufficiency of the legs: the pathophysiological basis of the physical-diagnostic studies].
    Bruyninckx CM
    Ned Tijdschr Geneeskd; 1990 Jul; 134(28):1353-6. PubMed ID: 2374624
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
    Toni E
    Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F
    Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Causes for rheographic signal changes].
    Gal'perin IuM; Raeva II
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1506-15. PubMed ID: 7439441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.